Cargando…
Optimizing the timing of nephrology referral for patients with diabetic kidney disease
Age-standardized rates of diabetes mellitus (DM)-related complications, such as acute myocardial infarction, stroke or amputations, have decreased in recent years, but this was not associated with a clear reduction of the incidence of advanced chronic kidney disease (CKD) requiring renal replacement...
Autores principales: | Martínez-Castelao, Alberto, Soler, María José, Górriz Teruel, José Luis, Navarro-González, Juan F, Fernandez-Fernandez, Beatriz, de Alvaro Moreno, Fernando, Ortiz, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857795/ https://www.ncbi.nlm.nih.gov/pubmed/33564400 http://dx.doi.org/10.1093/ckj/sfaa125 |
Ejemplares similares
-
SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020) -
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2019) -
EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors
por: Fernández-Fernandez, Beatriz, et al.
Publicado: (2023) -
COVID-19 and its impact on the kidney and the nephrology community
por: Soler, María José, et al.
Publicado: (2021) -
GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists
por: Górriz, José Luis, et al.
Publicado: (2020)